PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Scutellarin protects against doxorubicin-induced acute cardiotoxicity and regulates its accumulation in the heart.

Rat / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 28315259 ↗2017Reported benefit

Scutellarin protects against doxorubicin-induced acute cardiotoxicity and regulates its accumulation in the heart.

RatChemical/toxinSprague-DawleyMalen = Experiment 1: 32 rats, 4 groups of 8; experiment 2: 16 rats…Intravenous via tail vein5 mg/kg/day (pharmacodynamic study); single 5.0 mg/kg dose…First dose immediately after doxorubicin injection in the pharmacodynamic study…

Model: Doxorubicin-induced acute cardiotoxicity (single intraperitoneal dose of 20 mg/kg doxorubicin); pharmacokinetic experiments used a single intravenous 5 mg/kg doxorubicin dose

Scutellarin co-treatment reduced LDH activity from 4057.8 to 2595.9, malondialdehyde from 2.083 to 1.380 nmol/mg protein and cardiac troponin T from 0.1695 to 0.0222 ng/mL, and raised LVEF from 47.75 to 76.70% and LVFS from 20.66 to 40.28%, with markedly reduced cardiac histological damage. It lowe…

Extraction: extract · Supplied extraction confidence: 0.95. Machine-extracted fields require source verification.